全文获取类型
收费全文 | 25884篇 |
免费 | 2633篇 |
国内免费 | 527篇 |
专业分类
耳鼻咽喉 | 135篇 |
儿科学 | 1030篇 |
妇产科学 | 785篇 |
基础医学 | 613篇 |
口腔科学 | 175篇 |
临床医学 | 1915篇 |
内科学 | 2283篇 |
皮肤病学 | 141篇 |
神经病学 | 191篇 |
特种医学 | 494篇 |
外国民族医学 | 64篇 |
外科学 | 2453篇 |
综合类 | 3197篇 |
现状与发展 | 2篇 |
预防医学 | 545篇 |
眼科学 | 100篇 |
药学 | 2162篇 |
17篇 | |
中国医学 | 802篇 |
肿瘤学 | 11940篇 |
出版年
2024年 | 57篇 |
2023年 | 317篇 |
2022年 | 732篇 |
2021年 | 1009篇 |
2020年 | 888篇 |
2019年 | 811篇 |
2018年 | 813篇 |
2017年 | 927篇 |
2016年 | 1161篇 |
2015年 | 1074篇 |
2014年 | 1576篇 |
2013年 | 2105篇 |
2012年 | 1447篇 |
2011年 | 1661篇 |
2010年 | 1263篇 |
2009年 | 1285篇 |
2008年 | 1259篇 |
2007年 | 1411篇 |
2006年 | 1278篇 |
2005年 | 1075篇 |
2004年 | 863篇 |
2003年 | 782篇 |
2002年 | 690篇 |
2001年 | 627篇 |
2000年 | 516篇 |
1999年 | 492篇 |
1998年 | 388篇 |
1997年 | 395篇 |
1996年 | 283篇 |
1995年 | 263篇 |
1994年 | 252篇 |
1993年 | 167篇 |
1992年 | 138篇 |
1991年 | 135篇 |
1990年 | 109篇 |
1989年 | 100篇 |
1988年 | 86篇 |
1987年 | 76篇 |
1986年 | 62篇 |
1985年 | 78篇 |
1984年 | 70篇 |
1983年 | 60篇 |
1982年 | 41篇 |
1981年 | 45篇 |
1980年 | 41篇 |
1979年 | 34篇 |
1978年 | 34篇 |
1977年 | 26篇 |
1976年 | 27篇 |
1975年 | 10篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
51.
Background : The present paper addressed the issue of whether pretreatment with intravenous (IV) chemotherapy affects response rate or survival in patients receiving hepatic artery chemotherapy (HAC). Methods : Case note reviews of 164 patients treated in a teaching hospital from June 1990 to July 1996 were carried out. Results : The response rate and carcino-embryonic antigen (CEA) fall in the two groups was almost identical. There was a nonsignificant survival advantage in the non-pretreatment group. Conclusions : Previous administration of IV chemotherapy did not affect the CEA response of patients receiving HAC. 相似文献
52.
目的 探索早期乳腺癌保留乳房治疗的新途径。方法 1995 - 1997年采用术前动脉插管化疗加乳腺区段切除治疗Ⅰ、Ⅱ期乳腺癌共 2 6例 ,并随访 5年以上。结果 2 6例中 1例术后 2年 4个月死于肺转移 ,另 1例术后 4年死于其他疾病。 1例术后 1年复发 ,行全乳房切除后至今无瘤生存 6年。本组 3年生存率 (OS) 96 .15 % ,3年无瘤生存率 (DFS) 92 .3% ;5年OS 88.4 6 % ,5年DFS 88.4 6 %。结论 术前动脉插管化疗能提高肿瘤区域的药物浓度 ,杀灭部分癌细胞 ,减少术后复发。该疗法对部分Ⅰ、Ⅱ期乳腺癌病例是可行的。 相似文献
53.
Eigo Otsuji Toshiharu Yamaguchi Nozomi Yamaguchi Kunihiko Koyama Jiro Imanishi Nobuki Yamaoka Toshio Takahashi 《Surgery today》1992,22(4):351-356
In a previous study, we used a murine monoclonal antibody, A7, against human colon carcinoma as a drug-carrier to treat colorectal cancer.1 In the present study, we found that MAb A7 also reacted immunohistochemically with 73% of human pancreatic carcinoma cell lines, with the A7 antigen mainly being detected on the cell surface. However, the A7 antigen was found in only 9% of the spent media of these human pancreatic carcinoma cell lines by ELISA. On the other hand, the positive incidence of CA19-9, POA, ferritin, CEA, DU-PAN-2 and SLX in those spent media was 100%, 64%, 64%, 55%, 55% and 36%, respectively. These results suggest that the A7 antigen may only rarely be shed into the sera of pancreatic cancer patients, in which case MAb A7 could be a suitable drug-carrier in targeting chemotherapy for pancreatic cancer patients. 相似文献
54.
O. Reerink N. H. Mulder† B. G. Szabo W. J. Sluiter† T. Wiggers‡ A. H. H. Bongaerts§ G. A. P. Hospers† 《Colorectal disease》2004,6(6):406-417
Abstract The treatment options for primary irresectable rectal cancers are discussed. Assessment of tumour stage is the first step for an appropriate choice of treatment. Following a diagnosis of rectal cancer, a vast array of diagnostic procedures is available to determine its stage, and thereby its best treatment options. From the many (new) diagnostic options the merits and drawbacks are discussed. If a diagnosis of irresectability is made, further treatment options should include radiotherapy in most cases, some aspects of timing and application, i.e. intra-operative treatment are discussed. Chemotherapy options are manifold, the results are discussed and some new options are explored. 相似文献
55.
ISAO HARA SATOKO HIKOSAKA HIROSHI ETO HIDEAKI MIYAKE YUJI YAMADA TOSHINORI SOEJIMA KAZURO SUGIMURA SADAO KAMIDONO 《International journal of urology》2004,11(8):678-682
We report on two cases of women with locally advanced squamous cell carcinoma of the urethra. Patient 1 also displayed regional lymph node metastasis. Treatment comprised combined radiotherapy to 60 Gy and chemotherapy with 5-fluorouracil and cisplatin. Complete response was obtained in both patients, including the inguinal lymph nodes of Patient 1. Patient 1 experienced recurrent inguinal lymph node metastasis on the contralateral side at 42 months after initial treatment, and the same treatment was performed followed by surgical excision. Both patients remain alive with no evidence of disease, at 12 months after recurrence in Patient 1, and at 27 months after treatment in Patient 2. 相似文献
56.
ELFP方案治疗晚期鼻咽癌及上消化道癌疗效分析 总被引:3,自引:1,他引:2
目的探索ELFP方案治疗转移复发的晚期鼻咽癌、食管癌、胃癌的临床疗效和毒性.方法选择病理证实的64例晚期鼻咽癌、食管癌、胃癌采用Vp-16 0.1 g静滴,d1-3;CF 0.1 g静滴,d1-3 5-FU 0.5 g静滴,d1-3;DDP 50 mg静滴,d1-2;21 d为1周期.治疗2~6个周期.结果鼻咽癌,食管癌、胃癌有效率(CR PR)分别为75%、70%、43.8%,其中胃癌与鼻咽癌及食管癌分别比较有差异;单病灶与多病灶之间疗效无差异.全组病例总生存期为3~41月,中位生存期分别为11.5、10、7.5个月.主要毒性为骨髓抑制,其中Ⅲ、Ⅳ度白细胞下降占21.9%;Ⅲ、Ⅳ度血红蛋白下降占15.6%;Ⅲ、Ⅳ度血小板下降占3.1%.Ⅲ、Ⅳ度恶心、呕吐发生率为7.8%.结论ELFP对晚期鼻咽癌及食管癌有较好的疗效,其毒性可以耐受,是临床治疗鼻咽癌,食管癌切实可行的方案. 相似文献
57.
T. Terada K. Miyamoto G. Hyotani M. Tsuura Y. Nakamura T. Nishiguchi T. Itakura S. Hayashi N. Komai 《Acta neurochirurgica》1992,118(3-4):108-111
Summary Changes in tumour blood flow under an induced hypertensive state were examined in malignant brain tumours to know if the precondition for the effectiveness of induced hypertensive chemotherapy — relative increase in tumour blood flow — are fulfilled. Tumour blood flow was measured under both a resting and an induced hypertensive state in 12 patients with various malignant brain tumours (6 gliomas, 6 metastatic brain tumours) using xenon-enhanced computed tomography. The blood pressure was elevated 40% above the systemic blood pressure of the resting state by the infusion of angiotensin II. Tumour blood flow increased 30% on average above the normal brain tissue blood flow after the induction of an induced hypertensive state (p < 0.05). The tumour blood flow increased in 11 cases of malignant tumours, but decreased in one case with massive brain oedema after induced hypertension. The increase in blood flow was higher in hypervascular tumours and less in hypovascular tumours. Therefore, induced hypertensive chemotherapy probably will be more effective in hypervascular malignant brain tumours with small mass effects. 相似文献
58.
全植入式药泵行肝血管灌注治疗晚期肝癌 总被引:6,自引:2,他引:4
对24例不能切除的晚期肝癌采用完全植入式药泵行肝动脉和门静脉双灌注化疗。结果:部分缓解(PR)15例(62.5%),稳定(S)8例(33.3%),进展(P)1例。平均生存期为9.17月,半年生存率为66.7%,1年为25%。在AFP>400μg/L的10例中,5例下降。 相似文献
59.
�ٴ��� �������ٰ���ǰ�̳̻��Ƶ����� 总被引:5,自引:1,他引:4
目的 探讨临床Ⅰ、Ⅱ期乳腺癌术前短程化疗的意义。方法 122例临床Ⅰ、Ⅱ期乳腺癌术前用CEF方案化疗1疗程,化疗后3-5d手术。结果 部分缓解21例(占17.2%),轻度缓解76例(占62.3%),无变化25例(占20.5%),无临床进展病例。术前可扪及腋窝肿大淋巴结42例,化疗后30例见淋巴结明显缩小或消失。病理组织学观察75例镜下见肿瘤细胞有小点片状坏死。106例按计划手术;16例因白细胞降低等化疗反应推迟手术。全组随访1~6年,无局部复发病例;6例在随访期间1~3年内发现骨转移,经放疗和化疗控制;仅1例同时有骨转移和肺转移者于术后4年死亡;余均健在。结论 可手术乳腺癌的术前短程化疗可观察到肿瘤缩小等治疗效果,为术后化疗提供指导。并可能减少术中血行转移和提高疗效。 相似文献
60.
Intraperitoneal chemotherapy was administered to 13 patients with peritoneal carcinomatosis, using acute peritoneal dialysis catheters immediately before the administration of the chemotherapy. A total of 59 cycles were administered, with insertion of the corresponding catheter. There were no inflow or outflow problems and no insertion-related complications. With the removal of the catheter after its use, there is no risk of abdominal infections. 相似文献